DETOX PHARMA: what changed
What changed
DETOX PHARMA
NACE 70.200, Business and other management consultancy
filed annual accounts (NBB)
Net result for the year
€152,406
2024 · €85,869+€66,537
Equity
€107,406
2024 · €172,767-€65,361
Cash
€7,170
2024 · €8,871-€1,701
Balance sheet total
€1.9m
2024 · €1.9m-€91
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
- Other debts +€160,112
up €160,112 (+23.8%), from €672,571 to €832,682
- Debts after one year -€105,548
down €105,548 (-11.4%), from €926,261 to €820,712
- Profit (loss) carried forward -€65,361
down €65,361 (-55.5%), from €117,767 to €52,406
Income statement
- Financial income +€70,000
new in 2025: €70,000
- Gross operating margin -€2,964
down €2,964 (-2.3%), from €128,171 to €125,207
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€85,869
Gross operating margin
-€2,964
Depreciation
-€743
Other operating charges
+€63
Financial income
+€70,000
Financial charges
-€362
Taxes
+€542
Result 2025
€152,406
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€318,033
Investment
-€4,196
Financing
-€315,538
Cash 2024
€8,871
From operations (derived)
+€318,033
Net result for the year
+€152,406
Depreciation
+€4,003
Receivables within one year
-€1,418
Trade debts
-€5,195
Tax, wage and social debts
+€8,124
Other debts
+€160,112
Investment (derived)
-€4,196
Investment in fixed assets (net)
-€4,196
Financing
-€315,538
Debts after one year
-€105,548
Current portion of long-term debt
-€1,164
Short-term financial debts
+€8,941
Contributions, distributions and other
-€217,767
Cash 2025
€7,170
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,907,111 | €1,907,020 | -€91 | 0.0% |
| Fixed assets | 21/28 | €1,843,312 | €1,843,504 | +€192 | 0.0% |
| Tangible fixed assets | 22/27 | €3,305 | €3,498 | +€192 | +5.8% |
| Furniture and vehicles | 24 | €3,305 | €3,498 | +€192 | +5.8% |
| Financial fixed assets | 28 | €1,840,006 | €1,840,006 | = | 0.0% |
| Current assets | 29/58 | €63,799 | €63,516 | -€283 | -0.4% |
| Amounts receivable within one year | 40/41 | €54,928 | €56,346 | +€1,418 | +2.6% |
| Trade receivables | 40 | €54,928 | €56,346 | +€1,418 | +2.6% |
| Cash at bank and in hand | 54/58 | €8,871 | €7,170 | -€1,701 | -19.2% |
| Total equity and liabilities | 10/49 | €1,907,111 | €1,907,020 | -€91 | 0.0% |
| Equity | 10/15 | €172,767 | €107,406 | -€65,361 | -37.8% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €5,000 | €5,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €5,000 | €5,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €117,767 | €52,406 | -€65,361 | -55.5% |
| Amounts payable | 17/49 | €1,734,344 | €1,799,614 | +€65,270 | +3.8% |
| Amounts payable after more than one year | 17 | €926,261 | €820,712 | -€105,548 | -11.4% |
| Financial debts | 170/4 | €926,261 | €820,712 | -€105,548 | -11.4% |
| Amounts payable within one year | 42/48 | €808,083 | €978,902 | +€170,819 | +21.1% |
| Current portion of amounts payable after more than one year | 42 | €106,982 | €105,819 | -€1,164 | -1.1% |
| Financial debts | 43 | - | €8,941 | +€8,941 | |
| Credit institutions | 430/8 | - | €8,941 | +€8,941 | |
| Trade debts | 44 | €5,580 | €385 | -€5,195 | -93.1% |
| Suppliers | 440/4 | €5,580 | €385 | -€5,195 | -93.1% |
| Taxes, remuneration and social security | 45 | €22,950 | €31,075 | +€8,124 | +35.4% |
| Taxes | 450/3 | €22,950 | €31,075 | +€8,124 | +35.4% |
| Other amounts payable | 47/48 | €672,571 | €832,682 | +€160,112 | +23.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,261 | €4,003 | +€743 | +22.8% |
| Other operating charges | 640/8 | €63 | €0 | -€63 | -99.8% |
| Gross operating margin | 9900 | €128,171 | €125,207 | -€2,964 | -2.3% |
| Operating profit (loss) | 9901 | €124,847 | €121,204 | -€3,643 | -2.9% |
| Financial income | 75/76B | - | €70,000 | +€70,000 | |
| Recurring financial income | 75 | - | €70,000 | +€70,000 | |
| Financial charges | 65/66B | €15,969 | €16,330 | +€362 | +2.3% |
| Recurring financial charges | 65 | €15,969 | €16,330 | +€362 | +2.3% |
| Profit (loss) for the period before taxes | 9903 | €108,878 | €174,873 | +€65,995 | +60.6% |
| Income taxes | 67/77 | €23,009 | €22,467 | -€542 | -2.4% |
| Profit (loss) for the period | 9904 | €85,869 | €152,406 | +€66,537 | +77.5% |
| Profit (loss) for the period to be appropriated | 9905 | €85,869 | €152,406 | +€66,537 | +77.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.